Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
JINS HoldingsTSE:3046 -19.38%96 ROA % is 13.31% as of Feb. 2026, which is 54% above its 10-year median of 8.62. GuruFocus rates TSE:3046 with a GF Score™ of 96/100 and a GF Value™ of 円6,930.31 (Modestly Undervalued). Among 857 Medical Devices & Instruments companies, JINS Holdings ranks better than 93.7% on this metric.
ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. JINS Holdings's annualizedNet Income for the quarter that ended in Feb. 2026 was 円7,720 Mil.
JINS Holdings's average Total Assets over the quarter that ended in Feb. 2026 was 円58,003 Mil. Therefore, JINS Holdings's annualized ROA % for the quarter that ended in Feb. 2026 was 13.31%.
The historical rank and industry rank for JINS Holdings's ROA % or its related term are showing as below:
TSE:3046'
s ROA % Range Over the Past 10 Years
Min: 1.39 Med: 8.62 Max: 14.89
Current: 14.32
During the past 13 years, JINS Holdings's highest ROA % was 14.89%. The lowest was 1.39%. And the median was 8.62%.
TSE:3046's ROA % is ranked better than 93.7% of 857
companies
in the Medical Devices & Instruments industry
Industry Median: 0.55
vs TSE:3046: 14.32
JINS Holdings (TSE:3046) ROA % Explanation
ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A banks ROA % is typically well under 2%.
Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:
Note:
The Net Income data used here is four times the quarterly (Feb. 2026) net income data. The Revenue data used here is four times the quarterly (Feb. 2026) revenue data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.
E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.
JINS Holdings ROA % Related Terms
JINS Holdings ROA % Historical Data
* Premium members only.
The historical data trend for JINS Holdings's ROA % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, JINS Holdings's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
JINS Holdings ROA % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, JINS Holdings's ROA % distribution charts can be found below:
* The bar in red indicates where JINS Holdings's ROA % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is four times the quarterly (Feb. 2026) net income data.
ROA % is displayed in the 30-year financial page.
JINS Holdings (TSE:3046) has a ROA % of 13.31% as of Feb. 2026. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on JINS Holdings and its competitors. This is 54% above median its historical median of 8.62. Over the past decade, JINS Holdings' ROA % has ranged from 1.39 to 14.89. According to the industry distribution chart, JINS Holdings ranks #54 out of 857 companies in the Medical Devices & Instruments industry, placing it in the top 6.3%.
Is JINS Holdings' ROA % too high?
JINS Holdings' current ROA % of 13.31% is 54% above median its 10-year median of 8.62. Over the past 10 years, this metric has ranged from a low of 1.39 to a high of 14.89. The Medical Devices & Instruments industry median ROA % is 0.55. JINS Holdings' value of 13.31% is 2320% above this industry median. Based on the distribution chart, JINS Holdings ranks #54 out of 857 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, JINS Holdings has a GF Score™ of 96/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does JINS Holdings' ROA % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, JINS Holdings ranks #54 out of 857 companies for ROA %. This places JINS Holdings in the top 6% of its industry — outperforming the majority of peers. The industry median ROA % is 0.55. JINS Holdings' value of 13.31% is 2320% above this benchmark. Historically, JINS Holdings' own ROA % has ranged from 1.39 to 14.89 over the past decade. While the company's 10-year median is 8.62 vs. the industry median of 0.55, JINS Holdings has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROA % for a Medical Devices & Instruments company?
The median ROA % among Medical Devices & Instruments companies is 0.55, based on 857 companies in the industry. Companies in the top quartile (top 25%) have a ROA % significantly above this median, while those in the bottom quartile fall well below. However, ROA % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. JINS Holdings's current ROA % of 13.31% is 2320% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROA % mean?
A high ROA % can signal that a stock is expensive relative to its fundamentals. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on JINS Holdings and its competitors. For the Medical Devices & Instruments industry, the median ROA % is 0.55 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. JINS Holdings's current ROA % is 13.31%, which is 54% above median its own 10-year median of 8.62. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is JINS Holdings stock overvalued right now?
Based on GuruFocus' analysis, JINS Holdings (TSE:3046) is currently considered Modestly Undervalued. The stock's GF Value™ is 円6,930.31, compared to a current price of 円6,240.00 — trading 10% below its estimated fair value. The current ROA % is 13.31%, which is 54% above median its 10-year median of 8.62 and 2320% above the Medical Devices & Instruments industry median of 0.55. JINS Holdings' overall GF Score™ is 96/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROA % calculated?
ROA % is calculated from a company's financial statements. For JINS Holdings (TSE:3046), the current ROA % is 13.31% as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is JINS Holdings (TSE:3046) Overvalued in 2026?
Based on GuruFocus' analysis, JINS Holdings stock appears to be undervalued.
The current stock price of 円6,240.00 is trading 10% below its estimated GF Value™ of 円6,930.31.
GuruFocus considers JINS Holdings to be Modestly Undervalued.
Key valuation signals for TSE:3046:
ROA %: 13.31% (54% above median its 10-year median of 8.62)
GF Value™: 円6,930.31 vs. price of 円6,240.00 (10% below fair value)
Industry Position: 2320% above the Medical Devices & Instruments median (#54 of 857)
No single metric tells the full story. See the TSE:3046 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
JINS Holdings Inc is an eyewear retailer that manufactures and sells private-label fashion eyeglasses and sunglasses. It offers prescription eyeglasses and nonprescription fashion or functional eyeglasses. Its inventory is on the shelves, and it charges flat rates with generally no additional charges or options for lens features. Jin has more than 300 stores in Japan as well as locations in China, Taiwan, and the United States. Stores are typically located in high-traffic areas such as shopping centers, malls, and train stations.
96GF Score
Get the complete analysis for TSE:3046
ROA % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:3046 has been successfully added to your 
